To determine the effect of the insulin/IGF signaling pathway on AD, an AD mouse model with decreased IGF-1R signaling was generated by crossing the AβPPswe/PSEN1dE9 mice with Igf1r+/− mice. This evidence concerns the gene IGF1 and Alzheimer disease.